APA (7th ed.) Citation

K, P., L, A., & M, L. (2026). Neurokinin pathway antagonists for vasomotor symptoms in women with breast cancer: Focus on elinzanetant and fezolinetant. Breast (Edinburgh, Scotland), 88, 104812. https://doi.org/10.1016/j.breast.2026.104812

Chicago Style (17th ed.) Citation

K, Pogoda, Arecco L, and Lambertini M. "Neurokinin Pathway Antagonists for Vasomotor Symptoms in Women with Breast Cancer: Focus on Elinzanetant and Fezolinetant." Breast (Edinburgh, Scotland) 88 (2026): 104812. https://doi.org/10.1016/j.breast.2026.104812.

MLA (9th ed.) Citation

K, Pogoda, et al. "Neurokinin Pathway Antagonists for Vasomotor Symptoms in Women with Breast Cancer: Focus on Elinzanetant and Fezolinetant." Breast (Edinburgh, Scotland), vol. 88, 2026, p. 104812, https://doi.org/10.1016/j.breast.2026.104812.